U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula CH5N3O
Molecular Weight 75.0699
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYDROXYGUANIDINE

SMILES

NC(=N)NO

InChI

InChIKey=WFBHRSAKANVBKH-UHFFFAOYSA-N
InChI=1S/CH5N3O/c2-1(3)4-5/h5H,(H4,2,3,4)

HIDE SMILES / InChI

Molecular Formula CH5N3O
Molecular Weight 75.0699
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Dimerization of protegrin-1 in different environments.
2010-09-09
Reaction of N-hydroxyguanidine with the ferrous-oxy state of a heme peroxidase cavity mutant: a model for the reactions of nitric oxide synthase.
2010-08-01
Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif.
2010-02-25
The peptidylglycine alpha-amidating monooxygenase (PAM): a novel prodrug strategy for amidoximes and N-hydroxyguanidines?
2009-10
N-Hydroxyguanidines oxidation by a N3S copper-complex mimicking the reactivity of Dopamine beta-Hydroxylase.
2009-03
Synthesis of (+)- and (-)-monanchorin.
2009-02-19
Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
2008-04
2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors.
2007-11-15
Reactivity of the heme-dioxygen complex of the inducible nitric oxide synthase in the presence of alternative substrates.
2006-01
Total synthesis of (+)-batzelladine A and (-)-batzelladine D, and identification of their target protein.
2005-11-18
Metabolism of N-hydroxyguanidines (N-hydroxydebrisoquine) in human and porcine hepatocytes: reduction and formation of glucuronides.
2005-10
Nomega-hydroxy-L-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agents.
2005-06-15
Relationship between the structure of guanidines and N-hydroxyguanidines, their binding to inducible nitric oxide synthase (iNOS) and their iNOS-catalysed oxidation to NO.
2005-06
Arginase: structure, mechanism, and physiological role in male and female sexual arousal.
2005-03
N-hydroxyguanidines as substrates of nitric oxide synthases.
2005
Alternative nitric oxide-producing substrates for NO synthases.
2004-10-15
Design, synthesis, and biochemical evaluation of novel alpha V beta 3 integrin ligands.
2004-09-06
[Design, synthesis and antiasthmatic activities of NO-donating seratrodast derivatives].
2004-09
Synthesis and quantitative structure-activity relationship of hydrazones of N-amino-N'-hydroxyguanidine as electron acceptors for xanthine oxidase.
2004-06-03
Aromatic N-hydroxyguanidines as new reduction cosubstrates for dopamine beta-hydroxylase.
2004-04-16
Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscle.
2004-03-15
The mechanism of L-canavanine cytotoxicity: arginyl tRNA synthetase as a novel target for anticancer drug discovery.
2003-10
Oxidation of N-hydroxyguanidines by copper(II): model systems for elucidating the physiological chemistry of the nitric oxide biosynthetic intermediate N-hydroxyl-L-arginine.
2003-09-01
Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
2003-04-08
pH-dependent stability of sperm whale myoglobin in water-guanidine hydrochloride solutions.
2003-02
Microperoxidase 8 catalysed nitrogen oxides formation from oxidation of N-hydroxyguanidines by hydrogen peroxide.
2003-01
[Metalloporphyrin catalyzed biomimetic oxidation potentials: potential uses and applications].
2003
The novel binding mode of N-alkyl-N'-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis.
2002-11-26
Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
2002-11
Novel substrates for nitric oxide synthases.
2002-09
EPR and ENDOR characterization of intermediates in the cryoreduced oxy-nitric oxide synthase heme domain with bound L-arginine or N(G)-hydroxyarginine.
2002-08-20
Oxidation of N-hydroxyguanidines by cytochromes P450 and NO-synthases and formation of nitric oxide.
2002-08
Electrochemical and peroxidase oxidation study of N'-hydroxyguanidine derivatives as NO donors.
2002-06-03
Ceramide binding to African-American hair fibre correlates with resistance to hair breakage.
2002-02
N-hydroxyguanidines as new heme ligands: UV-visible, EPR, and resonance Raman studies of the interaction of various compounds bearing a C=NOH function with microperoxidase-8.
2001-08-21
Oxidations of N(omega)-hydroxyarginine analogues and various N-hydroxyguanidines by NO synthase II: key role of tetrahydrobiopterin in the reaction mechanism and substrate selectivity.
2001-02
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:08:08 GMT 2025
Edited
by admin
on Mon Mar 31 19:08:08 GMT 2025
Record UNII
8767F421T7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-529357
Preferred Name English
HYDROXYGUANIDINE
Common Name English
N-HYDROXYGUANIDINE
Systematic Name English
UREA, OXIME
Common Name English
N''-HYDROXYGUANIDINE
Systematic Name English
GUANIDINE, HYDROXY-
Systematic Name English
Code System Code Type Description
NSC
529357
Created by admin on Mon Mar 31 19:08:08 GMT 2025 , Edited by admin on Mon Mar 31 19:08:08 GMT 2025
PRIMARY
CHEBI
43089
Created by admin on Mon Mar 31 19:08:08 GMT 2025 , Edited by admin on Mon Mar 31 19:08:08 GMT 2025
PRIMARY
DRUG BANK
DB03770
Created by admin on Mon Mar 31 19:08:08 GMT 2025 , Edited by admin on Mon Mar 31 19:08:08 GMT 2025
PRIMARY
EPA CompTox
DTXSID00156915
Created by admin on Mon Mar 31 19:08:08 GMT 2025 , Edited by admin on Mon Mar 31 19:08:08 GMT 2025
PRIMARY
PUBCHEM
80668
Created by admin on Mon Mar 31 19:08:08 GMT 2025 , Edited by admin on Mon Mar 31 19:08:08 GMT 2025
PRIMARY
FDA UNII
8767F421T7
Created by admin on Mon Mar 31 19:08:08 GMT 2025 , Edited by admin on Mon Mar 31 19:08:08 GMT 2025
PRIMARY
CAS
13115-21-4
Created by admin on Mon Mar 31 19:08:08 GMT 2025 , Edited by admin on Mon Mar 31 19:08:08 GMT 2025
PRIMARY